Innovative Diagnostic Tools ProteoGenix specializes in developing advanced molecular diagnostic tools with the potential to revolutionize pregnancy and neonatal care, indicating opportunities for partnerships or sales of cutting-edge genomic and proteomic technologies.

Recent Product Launches The launch of proprietary products like the XtenCHO Transient Expression System Kit and the Human Immune COVID-19 library demonstrates ongoing innovation and product expansion, presenting prospects for sales of research reagents and diagnostic solutions.

Market Expansion Potential With a revenue range of 10 to 25 million dollars and a focus on life sciences research, ProteoGenix offers opportunities to collaborate or supply reagents, kits, and tech solutions to other biotech organizations or research labs seeking innovative diagnostic tools.

Niche Focus in Biotechnology Operating within the specialized biotechnology research industry with a focus on genomics and proteomics, ProteoGenix presents a targeted customer base of research labs and healthcare providers looking to adopt new diagnostic technologies.

Growing Expertise and Reputation As a company with a focused R&D effort and recent product development milestones, ProteoGenix is positioned as a trustworthy partner for collaborations in scientific research and commercial distribution of innovative biotech products.